FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/12/029563 [Registered on: 04/12/2020] Trial Registered Prospectively
Last Modified On: 03/12/2020
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Follow Up Study 
Study Design  Single Arm Study 
Public Title of Study   “AN OBSERVATIONAL STUDY OF HIGH FLOW NASAL OXYGEN THERAPY IN COVID 19 PATIENTS ADMITTED IN INTENSIVE CARE UNIT” 
Scientific Title of Study   An observational study of High Flow Nasal Oxygen Therapy in COVID-19 patients admitted in intensive care unit 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Ashwin sonkamble 
Designation  Associate professor 
Affiliation  Grant government medical college 
Address  Associate professor, Department of Anaesthesiology, 6th floor, main building, GGMC, JJ hospital campus.byculla
Associate professor, Department of Anaesthesiology, 6th floor, main building, GGMC, JJ hospital campus, byculla-08
Mumbai
MAHARASHTRA
400008
India 
Phone    
Fax    
Email  seeashwin@rediffmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ashwin sonkamble 
Designation  Associate professor 
Affiliation  Grant government medical college 
Address  Associate professor, department of Anaesthesiology, 6th floor, main building, GGMC JJ hospital campus,byculla
Associate professor, Department of Anaesthesiology, 6th floor, main building, GGMC, JJ hospital campus, byculla-08
Mumbai
MAHARASHTRA
400008
India 
Phone    
Fax    
Email  seeashwin@rediffmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Ashwin sonkamble 
Designation  Associate professor 
Affiliation  Grant government medical college 
Address  Associate professor, department of Anaesthesiology, ggmc, JJ hospital campus.byculla
Associate professor, Department of Anaesthesiology, 6th floor, main building, GGMC, JJ hospital campus, byculla 08
Mumbai
MAHARASHTRA
400008
India 
Phone    
Fax    
Email  seeashwin@rediffmail.com  
 
Source of Monetary or Material Support  
Grant government medical college, JJ hospital, Byculla, Mumbai 400008 
 
Primary Sponsor  
Name  Not applicable  
Address  Not applicable  
Type of Sponsor  Other [Not applicable ] 
 
Details of Secondary Sponsor  
Name  Address 
not applicable   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrAshwin sonkamble  St George Hospital  StGeorge Hospital,beside CST station, fort, Mumbai 400001
Mumbai
MAHARASHTRA 
9850961196

seeashwin@rediffmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethics committee, Grant government medical college   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: B972||Coronavirus as the cause of diseases classified elsewhere,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.Patients between age 18-60years
2.Both males and females
3.Patients with type 1 respiratory failure
4.Patients with SpO2 less than or equal to 92% on room air
5.Patients with or without co morbidities 
 
ExclusionCriteria 
Details  1.Patient’s refusal for HFNO
2.Patients below 18years and above 60years
3. Patients with tracheostomy
4. Patients with Claustrophobia
5.Patients with urgent need for endotracheal intubation
6.Patients with GCS less than 8 or raised intracranial tension
7.Patients with upper airway obstruction
8. Pregnant patients 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Whether high flow nasal oxygen therapy can treat hypoxia in COVID 19 patients   During ICU stay 
 
Secondary Outcome  
Outcome  TimePoints 
1.To analise failure rate of high flow nasal oxygen therapy in COVID 19 patients and escalation to invasive and non-invasive ventilation.   during ICU stay 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   10/12/2020 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL  
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is an observational study of  the utility of HFNO therapy in managing respiratory failure in moderate to severe COVID 19 patients who are admitted in intensive care unit and also to identify the early predictors of HFNO failure. 
Close